COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

National Weight-Loss Study Open At Moores UCSD Cancer Center

 

April 10, 2007  |  

Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modification. Study participants will receive at no cost medical evaluations, individualized diet and exercise programs, weekly nutritional and lifestyle group sessions, and the investigational study drugs or placebo.

The UCSD and Scripps collaboration represents one of nine study sites in the U.S. The study drugs have been shown to be safe and effective in preliminary clinical trials and are FDA approved for other conditions but not yet for weight loss.

To be eligible for this study, an individual must be obese, a non-smoker for at least six months, between 18 and 65 years of age, non-diabetic and in overall good health.

For further information, call the clinical research coordinator at UCSD Moores Cancer Center, 858-822-2779.

# # #

Media Contact:  Nancy Stringer,  619-543-6163, nstringer@ucsd.edu




Media Contact

Share This Article


Related News

4/15/2021
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale ...
4/14/2021
The UC San Diego Autism Center for Excellence has received a $1.5 million gift from Kristin Farmer, founder and chief executive officer of ACES, a company that provides services to children with autis ...
4/2/2021
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
4/1/2021
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.



Follow Us